Apellis Pharmaceuticals Inc : William Blair Initiates Coverage With Outperform Rating; Fair Value Estimate $50
Apellis製藥公司:William Blair發起覆蓋,並給予超越市場評級;公允價值估計爲50美元
Apellis Pharmaceuticals Inc : William Blair Initiates Coverage With Outperform Rating; Fair Value Estimate $50
Apellis製藥公司:William Blair發起覆蓋,並給予超越市場評級;公允價值估計爲50美元
譯文內容由第三人軟體翻譯。